Navigation Links
AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
Date:4/4/2013

tly involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the uncertain timing of completion of and the success of clinical trials and the potential problems that may arise in the clinical development process, the uncertain and time-consuming regulatory filing and approval process, the availability of resources to develop Rigel's product candidates, the uncertain therapeutic and commercial value of fostamatinib, market competition, risks associated with and Rigel's dependence on Rigel's corporate partnerships, as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2012. Rigel does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein.CONTACTS Rigel Investor EnquiriesRaul RodriguezPhone: 650.624.1302Email: invrel@rigel.comRigel Media EnquiriesMedia Contact: Susan C. Rogers, Alchemy Consulting, Inc.Phone: 650.430.3777Email: susan@alchemyemail.comAstraZeneca Media EnquiriesEsra Erkal-Paler

+44 20 7604 8030 (UK/Global)Vanessa Rhodes

+44 20 7604 8037 (UK/Global)Ayesha Bharmal

+44 20 7604 8034 (UK/Global)Jacob Lund

+46 8 553 260 20 (Sweden)AstraZeneca Investor EnquiriesJames Ward-Lilley

+44 20 7604 8122

mob: +44 7785 432613Karl Hard

+44 20 7604 8123

mob: +44 7789 654364Colleen Proctor

+1 302 886 1842

mob: +1 302 357 4882Ed Seage

+1 302 886 4065

mob: +1 302 373 1361 


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
2. AstraZeneca And Cellworks Collaborate To Find New Treatment For Tuberculosis
3. Genpact and AstraZeneca Win Outsourcing Center and SSON Awards
4. AstraZeneca Acquires Neuroscience Assets From Link Medicine
5. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
6. Founded by Enlight Biosciences, KNODE partners with AstraZeneca and Other Partners
7. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
8. AstraZeneca And The Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents
9. Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer
10. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
11. AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
(Date:3/26/2015)... and VANCOUVER, British Columbia, March 26, 2015 /PRNewswire/ ... provided a summary of clinical developments and announced ... Clinical Developments and Anticipated Near-term ... OncoGenex and Teva agreed to negotiate the termination ... OncoGenex. Negotiations of the final termination agreement are ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2
(Date:3/27/2015)... The Thomas Scattergood Behavioral ... foundation committed to raising its voice to improve ... , The Scattergood Foundation and The Kennedy Forum ... and Practice through the Annual Scattergood Foundation Innovation ... is designed to guide the IBS sufferer through ...
(Date:3/26/2015)... 26, 2015 Elfster.com, the top-rated Secret ... its bucket list generator capabilities to its leading Secret ... to a list that one creates of things to ... movie of the same name. Nowadays many millennials ... memorialize their summer achievements. , "We are greatly expanding ...
(Date:3/26/2015)... TX (PRWEB) March 26, 2015 ... the 32nd annual Dallas Rhinoplasty Symposium and has ... years, reiterated the importance of evidence based medicine (EBM), ... evidence from well conducted research. , "We often hear ... to rhinoplasty, and while we are certainly not trying ...
(Date:3/26/2015)... Franklin, TN (PRWEB) March 26, 2015 ... http://www.healthclick.com . This website is dedicated to providing information ... therapy and occupation therapy community. As a leader ... North American Seminars provided over 200 live and online ... PT OT continuing Education Courses :, A Master Clinicians ...
(Date:3/26/2015)... Francisco, CA (PRWEB) March 26, 2015 The ... These will be on the topics of the DAOM Program ... The DAOM Program Overview Webinar will be hosted by Dr. ... and provide the next steps on how to prepare for ... 12:30 p.m. March 25, March 27, April 1 and April ...
Breaking Medicine News(10 mins):Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:ACTCM Announces Upcoming Webinars 2
... community outreach program in Delaware has thought of an ... ,Its “Do the Right Thing 4Life” program—supported by AIDS ... well as condoms, to people via the participating barbershops ... by Frank Hawkins, director of education and community outreach ...
... low fat diet into old age, according to a new ... study on nearly 50,000 post-menopausal women in the US, //published ... Association (JAMA), comes to the conclusion that reducing fat intake ... to maintain a stable weight. , ,This discredits ...
... weed, which contains a chemical called cannabinoids which contains a ... “high” effect on the brain. // Due to its high ... be cultivated as an indoor plant under the lamps without ... than 20 times of THC than the one cultivated 30 ...
... WinRho drug, used for treating bleeding disorders. According to Baxter ... to trigger fatal side effects, albeit rarely.// ... States since 1995, and is used to treat a bleeding ... with requisite number of platelets, to form clots. Winrho-related complications ...
... It has been known for long now that Vitamin D ... that Vitamin D supplementation in pregnant// women could lead to ... to a study it has been shown that children whose ... to have weaker bones. ,It is a common ...
... NHS could suffer a big blow if the financial condition ... the Audit Commission.// The prevalence of a weak financial management, ... by district auditors have been accounted for the present condition. ... trusts and hospitals is believed to reach ?75m by the ...
Cached Medicine News:Health News:NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey 2
... determination of Estradiol (E2) concentration in human serum ... hormone with a phenolic A ring. This ... It is the most potent natural Estrogen, ... smaller amounts by the adrenal cortex, and the ...
... potent, naturally secreted estrogen and is the ... In the ovary, estradiol is produced from ... potent estrogen derived from androstenedione. Estrone and ... In men, small amounts of estradiol are ...
... VITROS ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The VITROS ECi can simultaneously process ...
Clinical marker immunoassay kit for detection of Myoglobin....
Medicine Products: